Task: Answer the multiple-choice question.
Question: Which drug exhibits a 8.282% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)NCCCC(=O)O
b) N#Cc1ccccc1NC(=O)Nc1ccccc1
c) COc1ccc(NC(=S)N(Cc2cccnc2)Cc2ccco2)cc1
Answer: a. CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)NCCCC(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)NCCCC(=O)O
CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)NCCCC(=O)O
4-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]butanoic acid